Inhibition of the motor protein Eg5/Kinesin-5 in amyloid β-mediated impairment of hippocampal long-term potentiation and dendritic spine loss

RK Freund, ES Gibson, H Potter, ML Dell'Acqua - Molecular Pharmacology, 2016 - ASPET
Alzheimer's disease (AD) is characterized by neurofibrillary tangles, amyloid plaques, and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …
被引用次数：26 相关文章
[HTML] nih.gov

[HTML][HTML] Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss

RK Freund, ES Gibson, H Potter… - Molecular …, 2016 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is characterized by neurofibrillary tangles, amyloid plaques, and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …

[引用][C] Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss

RK Freund, ES Gibson, H Potter… - Molecular …, 2016 - cir.nii.ac.jp
Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of
Hippocampal Long-Term Potentiation and Dendritic Spine Loss | CiNii Research CiNii 国立 …

Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.

RK Freund, ES Gibson, H Potter… - Molecular …, 2016 - europepmc.org
Alzheimer's disease (AD) is characterized by neurofibrillary tangles, amyloid plaques, and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …
[PDF] researchgate.net

[PDF][PDF] Inhibition of the motor protein Eg5/Kinesin-5 in amyloid beta-mediated impairment of hippocampal long-term potentiation and dendritic spine loss

RK Freund, ES Gibson, H Potter, ML Dell'Acqua… - researchgate.net
Alzheimer's Disease (AD) is characterized by neurofibrillary tangles, amyloid plaques and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …

Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss

RK Freund, ES Gibson, H Potter… - Molecular …, 2016 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is characterized by neurofibrillary tangles, amyloid plaques, and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …

Inhibition of the motor protein Eg5/Kinesin-5 in amyloid beta-mediated impairment of hippocampal long-term potentiation and dendritic spine loss

RK Freund, ES Gibson, H Potter, ML Dell'Acqua - Molecular Pharmacology, 2016 - ASPET
Alzheimer9s Disease (AD) is characterized by neurofibrillary tangles, amyloid plaques and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …
[PDF] academia.edu

[PDF][PDF] Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid b-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss

RK Freund, ES Gibson, H Potter… - MOLECULAR …, 2016 - academia.edu
AlzheimerLs disease (AD) is characterized by neurofibrillary tangles, amyloid plaques, and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …

Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.

RK Freund, ES Gibson, H Potter… - Molecular …, 2016 - europepmc.org
Alzheimer's disease (AD) is characterized by neurofibrillary tangles, amyloid plaques, and
neurodegeneration. However, this pathology is preceded by increased soluble amyloid beta …